Glycoprotein metabolism disease
MONDO:0045010A disease that has its basis in the disruption of glycoprotein metabolic process.
Also known as: disorder of glycoprotein metabolic process, disorder of glycoprotein metabolism, glycoprotein metabolic process disease, glycoprotein metabolism disease
22 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Back surgery boost: Bone-Marrow injection may repair discs
Disease control Recruiting nowThis study tests whether adding a bone-marrow concentrate injection during routine back surgery helps the spinal disc heal better. About 90 adults with a herniated disc will get either surgery alone or surgery plus the injection. Researchers will use MRI scans and pain questionna…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Gene therapy trial offers hope for rare muscle disease
Disease control Recruiting nowThis study tests a single dose of a gene therapy called AB-1003 in 10 adults with a rare genetic muscle disease (LGMD2I/R9). The goal is to see if it is safe and can help improve muscle function. Participants must be able to walk or run 10 meters in under 30 seconds.
Phase: PHASE1, PHASE2 • Sponsor: AskBio Inc • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Scientists track rare glycosylation disorders to unlock disease secrets
Knowledge-focused Recruiting nowThis study follows people with congenital disorders of glycosylation (CDG) — rare genetic conditions that affect how the body builds sugar chains on proteins. Researchers aim to track how the disease progresses over time, including its impact on organs and thinking abilities. By …
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Major study aims to better measure muscular dystrophy progression
Knowledge-focused Recruiting nowThis 24-month observational study will follow up to 1000 people with certain types of muscular dystrophy (LGMD, DM2, and late-onset Pompe disease) aged 6-50. Researchers want to see if specific physical tests, like the North Star Assessment and a 100-meter walk, are good ways to …
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC